INNOCARE PHARMA LIMITED

Insiders InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Delayed Hong Kong S.E. Other stock markets 11:57:29 2024-05-12 pm EDT			5-day change	1st Jan Change
5.09 ^HKD	-0.20%		-4.86%	-26.12%

Mar. 29	InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib	CI
Mar. 28	Transcript : InnoCare Pharma Limited, 2023 Earnings Call, Mar 28, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

InnoCare Elects CFO	Dec. 18	MT
InnoCare Pharma Appoints Xin Fu as Chief Financial Officer	Dec. 17	CI
Innocare Pharma Limited Announces the Appointment of Dandan Dong as Independent Non-Executive Director	23-10-11	CI
RemeGen Names CFO	23-09-28	MT
Innocare Pharma Limited Announces Board Changes	23-07-14	CI
InnoCare Pharma Limited Announces Shan Fu Resigned as A Non-Executive Director with Effect from 27 March 2023	23-03-27	CI
InnoCare CFO Resigns	23-01-02	MT
Innocare Pharma Limited Announces Executive Changes	22-03-31	CI
InnoCare Pharma Limited Announces Executive Changes	22-03-22	CI
InnoCare Pharma Appoints Dr. Sean Zhang as Chief Medical Officer	21-02-28	CI
InnoCare Pharma Limited Announces Change of the Chief Medical Officer	21-02-28	CI
InnoCare Pharma Limited Announces Change of Company Secretary	21-02-08	CI
InnoCare Pharma Limited Appoints Manish Tandon as Vice President of Business Development	20-10-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW